The Current Ratio as of June 2025 (TTM) for Ascentage Pharma Group International (ASPHF) is 1.26

According to Ascentage Pharma Group International’s latest financial reports and current stock price. The company's current Current Ratio is 1.26. This represents a change of -30.62% compared to the average of 1.82 of the last 4 quarters.

Ascentage Pharma Group International (ASPHF) Historical Current Ratio (quarterly & annually)

How has ASPHF Current Ratio performed in the past?

The mean historical Current Ratio of Ascentage Pharma Group International over the last ten years is 4.31. The current 1.26 Current Ratio has changed 2.83% with respect to the historical average. Over the past ten years (40 quarters), ASPHF's Current Ratio was at its highest in in the December 2018 quarter at 9.41. The Current Ratio was at its lowest in in the January 2016 quarter at 0.

Ascentage Pharma Group International (ASPHF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ascentage Pharma Group International Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascentage Pharma Group International (ASPHF) Average Current Ratio

How has ASPHF Current Ratio performed in the past?

The current Current Ratio of Ascentage Pharma Group International (ASPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ascentage Pharma Group International (ASPHF) Current Ratio vs. Peers

How is ASPHF’s Current Ratio compared to its peers?

Ascentage Pharma Group International’s Current Ratio is less than Cellectis S.A. (1.73), less than Biotron Limited (1.83), less than Dermata Therapeutics, Inc. (6.97), greater than Kane Biotech Inc. (0.43), less than Covalon Technologies Ltd. (8.12), greater than Bioasis Technologies Inc. (0), less than Antibe Therapeutics Inc. (15.03), greater than Arch Therapeutics, Inc. (0.10), greater than Awakn Life Sciences Corp. (0.40), greater than Protagenic Therapeutics, Inc. (0.86), greater than Sino Biopharmaceutical Limited (1.26), greater than ZIVO Bioscience, Inc. (0.39), less than Cyteir Therapeutics, Inc. (28.07), less than Eledon Pharmaceuticals, Inc. (13.91), less than Applied Molecular Transport Inc. (4.24), less than Catalyst Biosciences, Inc. (3.60), less than Aileron Therapeutics, Inc. (2.38), greater than Bio-Path Holdings, Inc. (0.45), less than Benitec Biopharma Inc. (14.80),

Build a custom stock screener for Ascentage Pharma Group International (ASPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascentage Pharma Group International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascentage Pharma Group International (ASPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascentage Pharma Group International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.